IGSB Fellow Aaron Dinner- New technique will probe hidden dynamics of molecular biology
March 3, 2010
Funded by a $1 million grant from the W.M. Keck Foundation, University of Chicago scientists are aiming to develop a systematic method for determining how biological processes emerge from molecular interactions. The method may permit them to “rewire” the regulatory circuitry of insulin-secreting pancreatic beta cells, which play a major role in type-2 diabetes.
“Despite the enormous amount of study directed at diabetes, there’s really very little understanding of the collective mechanisms that govern or regulate insulin secretion,” said project director Aaron Dinner, Associate Professor in Chemistry.
A second goal: to control cell behavior and function more generally, which may ultimately culminate in other applications, including the bioremediation of environmental problems. Collaborating with Dinner on the project are Louis Philipson, PhD’82, MD ’86, Professor in Medicine and Director of the University of Chicago Kovler Diabetes Center; and chemistry professors Rustem Ismagilov and Norbert Scherer, SB’82.
The four scientists share an interest in the collective behavior of cells that emerges from groups of atoms and molecules working in concert at varying scales of time and space. “In a living system you have this hierarchy of coupled time and length scales,” Dinner said. “How is it that all of these different dynamics at one time and length scale get coupled to dynamics at another scale?”
The collaborators have worked together previously in various pairs. “It seemed natural to put those different pair-wise interactions together,” Dinner said.
Philipson and Scherer, for example, worked together to pioneer a microscopy method for imaging activity inside beta cells that led to insulin secretion under certain conditions. Ismagilov and Philipson collaborated on a means of efficiently measuring and analyzing beta-cell secretions. And Dinner and Scherer have analyzed the dynamics of an oddly behaving RNA molecule.
Non-intuitive molecular behavior
Dinner and Scherer’s study revealed some non-intuitive, hidden dynamics. They experimented with the molecule in solution, expecting it to move slowly, somewhat like a person walking around in a swimming pool. But after changing the chemical solution they found that the molecule behaved in a non-intuitive way.
“It was as though something was driving it,” Dinner said.
The chemical pulses they had introduced into the molecule’s watery environment were the driving force of the dynamic oscillations they observed. In their next step, they applied the process to a bacterium, coupling cycles inside the cell that would ordinarily operate on different time scales. The scientists then analyzed the bacterium’s response to the chemical pulses for insights into its internal properties.
The similar use of optical, magnetic and spectroscopic techniques is a standard means of probing molecular dynamics. Based on their RNA research, Scherer and Dinner realized that a chemical version of the technique might provide a whole new way of studying cellular dynamics. They call their new technique “chemical perturbation spectroscopy.”
“We measure everything at a single-cell level so we can quantify in detail what each single cell is doing as it evolves through multiple generations,” Scherer said. “These studies are allowing us to lay the groundwork for how to measure perturbations that we apply to cells, and how to do the analysis. Essentially, none of this has been put together before, so we have to invent an integrated approach.”
Once the details are worked out, Scherer said, “We expect to be able to target certain cell functions and, let’s say, increase insulin output from the beta cells.”
By Steve Koppes
Latest News
IGSB Senior Fellow Janet Rowley wins the 2012 Japan Prize for Healthcare and Medical Technology
Janet Davison Rowley, MD, the Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics & Cell Biology and Human Genetics at the University of Chicago, will share the 2012 Japan Prize for Healthcare and Medical Technology with Brian J. Druker, MD, from the Oregon Health and Science University, and Nicholas B. Lydon, PhD, formerly with Novartis. They were chosen for their roles in the development of the first precisely targeted anti-cancer drug, called imatinib (Gleevec®). Press Release
IGSB Fellow Habibul Ahsan receives named professorship
Habibul Ahsan, MD, MMedSc, professor in the departments of health studies, human genetics and medicine, director of the Center for Cancer Epidemiology and Prevention at the University of Chicago Medical Center and associate director of the University of Chicago Comprehensive Cancer Center, has been named a Louis Block Professor. Press Release
Top Japanese Scientist leaving government post to move to the University of Chicago Medical Center
“Dr. Nakamura has made major contributions to modern genetics and genomics,” said Kenneth Polonsky, MD, Dean of the Biological Sciences Division and the Pritzker School of Medicine at the University of Chicago. “We are extremely gratified by his interest in continuing his illustrious career at the University of Chicago.” Press Release
IGSB Core Faculty Robert Grossman appointed Chief Research Informatics Officer of the Division of the Biological Sciences
Robert Grossman, PhD, assumed the role of chief research informatics officer and is currently overseeing a research group focused on bioinformatics, data mining, data intensive computing and related areas. Press Release
